Floatz logo

Monomethyl Fumarate

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Medical College of WisconsinSmall moleculePhase 2Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Precursor B-Cell Lymphoblastic Leukemia-Lymphoma cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Medical College of Wisconsin
Phase 2BB
cc-5013
Institut de Cancérologie de la Loire
Phase 2B

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →